NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024
NHS England
Published on NHS Health Family Atamis procurement portal
This tender has closed
The submission deadline for this contract has passed. There may be more active goods tenders from NHS England, and hundreds more across the UK public sector.
Key details
Procurement
- 33600000 Pharmaceutical products
What happened
NHS England awarded this contract to Bayer Plc | Teva UK Limited | Roche Products Ltd | Thornton and Ross Ltd | Abbvie Ltd | Biogen | Novartis Pharmaceuticals UK Ltd | Alimera Sciences | Orion Pharma (UK) Ltd worth £416,830,570 on 25 Jul 2024. The contract runs until 31 Jul 2025.
Description
roject title: CM/PHS/24/5707 NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 Period of framework: 1 August 2024 to 31 July 2025. with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Awarded suppliers (9)
- Bayer Plc
- Teva UK Limited
- Roche Products Ltd
- Thornton and Ross Ltd
- Abbvie Ltd
- Biogen
- Novartis Pharmaceuticals UK Ltd
- Alimera Sciences
- Orion Pharma (UK) Ltd
Contact
Identifiers
Explore related tenders
Other tenders from NHS England
View all →External ID: cf-ocds-b5fd17-ad1eb5bd-7770-4a4f-b132-e66ff4702142 • Added 3 October 2026